JP2019089829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019089829A5 JP2019089829A5 JP2019023946A JP2019023946A JP2019089829A5 JP 2019089829 A5 JP2019089829 A5 JP 2019089829A5 JP 2019023946 A JP2019023946 A JP 2019023946A JP 2019023946 A JP2019023946 A JP 2019023946A JP 2019089829 A5 JP2019089829 A5 JP 2019089829A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- compound
- crystal
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789335P | 2013-03-15 | 2013-03-15 | |
| US61/789,335 | 2013-03-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502851A Division JP2016517435A (ja) | 2013-03-15 | 2014-03-14 | メロペネム誘導体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019089829A JP2019089829A (ja) | 2019-06-13 |
| JP2019089829A5 true JP2019089829A5 (cg-RX-API-DMAC10.html) | 2019-08-08 |
| JP6738918B2 JP6738918B2 (ja) | 2020-08-12 |
Family
ID=51537664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502851A Ceased JP2016517435A (ja) | 2013-03-15 | 2014-03-14 | メロペネム誘導体及びその使用 |
| JP2019023946A Expired - Fee Related JP6738918B2 (ja) | 2013-03-15 | 2019-02-13 | メロペネム誘導体及びその製造法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502851A Ceased JP2016517435A (ja) | 2013-03-15 | 2014-03-14 | メロペネム誘導体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9725451B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2968274B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2016517435A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2014227737B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112015023621A8 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2906689A1 (cg-RX-API-DMAC10.html) |
| HK (1) | HK1219233A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014144285A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111362239B (zh) * | 2020-03-20 | 2021-07-06 | 辽宁瑞鸥新材料科技有限公司 | 一种用于铝硅系合金半固态制浆的Cs2HPO4气溶胶及其使用方法 |
| CN112076161B (zh) * | 2020-08-07 | 2022-10-18 | 安徽康正康仁药业有限公司 | 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂 |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| CA3216616A1 (en) * | 2021-04-27 | 2022-11-03 | Philip V. Felice | Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of use |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA84584B (en) * | 1983-01-28 | 1984-09-26 | Bristol Myers Co | Substituted vinyl cephalosporins |
| DE3475065D1 (en) * | 1983-06-23 | 1988-12-15 | Merck & Co Inc | (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives |
| US4914091A (en) * | 1984-04-02 | 1990-04-03 | American Cyanamid Company | Esters of cephalosporin derivitives |
| JPS6247874A (ja) | 1985-08-27 | 1987-03-02 | Sankyo Seiki Mfg Co Ltd | プログラム動作装置の初期化方法 |
| GB9202298D0 (en) | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| JPH06192273A (ja) * | 1992-10-26 | 1994-07-12 | Lederle Japan Ltd | カルバペネム−３−カルボン酸エステル誘導体 |
| AU3649697A (en) * | 1996-06-27 | 1998-01-14 | G.D. Searle & Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| JP2000344773A (ja) * | 1998-07-17 | 2000-12-12 | Kyoto Pharmaceutical Industries Ltd | カルバペネム誘導体、およびその用途並びにその中間体化合物 |
| JP2000344772A (ja) | 1998-05-01 | 2000-12-12 | Kyoto Pharmaceutical Industries Ltd | カルバペネム誘導体、その用途およびその中間体化合物 |
| SK16382000A3 (sk) | 1998-05-01 | 2001-05-10 | Kyoto Pharmaceutical Industries, Ltd. | Karbapénové deriváty, ich vyžitie a ich medziproduktové zlúčeniny |
| JP2000344774A (ja) * | 1999-06-03 | 2000-12-12 | Meiji Seika Kaisha Ltd | カルバペネム類の製造法 |
| YU92003A (sh) * | 2001-05-21 | 2006-05-25 | Kyoto Pharmaceutical Industries Ltd. | Karbapenem jedinjenje |
| US20050065141A1 (en) | 2003-07-31 | 2005-03-24 | Odink Debra A. | Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereof |
| EP2085084A1 (en) * | 2008-01-29 | 2009-08-05 | LEK Pharmaceuticals D.D. | Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics |
| BR112013009531A2 (pt) * | 2010-11-11 | 2016-07-19 | Redx Pharma Ltd | derivados de fármaco |
| WO2013088255A1 (en) * | 2011-12-15 | 2013-06-20 | Alkermes Pharma Ireland Limited | Prodrugs of secondary amine compounds |
| CN111700878A (zh) | 2012-05-03 | 2020-09-25 | 卡拉制药公司 | 显示提高的粘膜转移的药物纳米粒子 |
-
2014
- 2014-03-14 EP EP14762750.9A patent/EP2968274B1/en active Active
- 2014-03-14 CA CA2906689A patent/CA2906689A1/en not_active Abandoned
- 2014-03-14 HK HK16107322.6A patent/HK1219233A1/zh unknown
- 2014-03-14 WO PCT/US2014/028627 patent/WO2014144285A1/en not_active Ceased
- 2014-03-14 AU AU2014227737A patent/AU2014227737B2/en not_active Ceased
- 2014-03-14 JP JP2016502851A patent/JP2016517435A/ja not_active Ceased
- 2014-03-14 US US14/777,018 patent/US9725451B2/en not_active Expired - Fee Related
- 2014-03-14 BR BR112015023621A patent/BR112015023621A8/pt not_active Application Discontinuation
-
2017
- 2017-07-14 US US15/650,667 patent/US10392388B2/en active Active
-
2018
- 2018-05-01 AU AU2018203005A patent/AU2018203005A1/en not_active Abandoned
-
2019
- 2019-02-13 JP JP2019023946A patent/JP6738918B2/ja not_active Expired - Fee Related
- 2019-07-11 US US16/509,388 patent/US11091487B2/en not_active Expired - Fee Related
-
2021
- 2021-07-07 US US17/369,806 patent/US20210332048A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5774732B2 (ja) | モキシフロキサシン塩酸塩の合成方法 | |
| WO2018149359A1 (zh) | 三氮唑抗菌衍生物、其药物组合物和用途 | |
| HU229935B1 (en) | Dual action antibiotics | |
| JP2008519788A5 (cg-RX-API-DMAC10.html) | ||
| US9840467B2 (en) | Arylhydrazides containing a 2-pyridone moiety as selective antibacterial agents | |
| JP2002505328A (ja) | 抗潰瘍医薬の硝酸塩 | |
| JP2010517983A5 (cg-RX-API-DMAC10.html) | ||
| JP2011162553A (ja) | ベンゾキノリジン−２−カルボン酸アルギニン塩四水和物 | |
| SK282545B6 (sk) | Kryštalické adičné soli cefému s kyselinami, spôsob ich výroby, ich použitie a liečivo s ich obsahom | |
| JP2019524829A5 (cg-RX-API-DMAC10.html) | ||
| JP2015143209A (ja) | ピリドンカルボン酸系抗菌薬のアルコキシカルボニルヘミアセタール型エステルプロドラッグ | |
| JP2001512725A (ja) | キノリジンカルボン酸誘導体 | |
| JP6077725B1 (ja) | 呼吸器感染症治療剤 | |
| JP2645091B2 (ja) | ７‐（２‐メチル‐４‐アミノピロリジニル）ナフチリジン及びキノリン化合物 | |
| WO2011121596A2 (en) | Crystal modification of moxifloxacin hydrochloride | |
| JP7645874B2 (ja) | シデロフォア・セファロスポリン・コンジュゲートおよびその使用 | |
| WO2014161412A1 (zh) | 一类三环喹诺酮衍生物及其制备方法和用途 | |
| JP6402120B2 (ja) | グラム陽性病原菌に対する活性のある新規の１，２，４−オキサジアゾール化合物 | |
| JP2007519701A5 (cg-RX-API-DMAC10.html) | ||
| CN115066417A (zh) | 凝血因子XIa抑制剂 | |
| JP2012524796A5 (cg-RX-API-DMAC10.html) | ||
| JP2002507616A5 (cg-RX-API-DMAC10.html) | ||
| CN102040615B (zh) | 含有二氢吡咯并环烷基的头孢抗生素 | |
| JPWO2021066175A5 (cg-RX-API-DMAC10.html) | ||
| CN1449384A (zh) | 新颖的酯或酰胺衍生物 |